Biodesix
BDSX
38 hedge funds and large institutions have $34.1M invested in Biodesix in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
11% more capital invested
Capital invested by funds: $30.7M → $34.1M (+$3.36M)
3% more funds holding
Funds holding: 37 → 38 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
0.16% less ownership
Funds ownership: 1.1% → 0.94% (-0.16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$124K |
| 2 |
TAM
Telemark Asset Management
Boston,
Massachusetts
|
+$119K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$93K |
| 4 |
Millennium Management
New York
|
+$90.6K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$77.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$389K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$330K |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$162K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$95.1K |
| 5 |
HF
HRT Financial
New York
|
-$61K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citadel Advisors
Miami,
Florida
| $48.2K | -$28.9K | -922 | -41% |
|
|
ECM
27
ExodusPoint Capital Management
New York
| $44K | +$37.6K | +1,198 | New |
|
|
HF
28
HRT Financial
New York
| $43K | -$61K | -1,942 | -62% |
|
29
Charles Schwab
San Francisco,
California
| $37.9K | – | – | – |
|
30
Morgan Stanley
New York
| $37.3K | +$15.1K | +480 | +90% |
|
31
Commonwealth Equity Services
Waltham,
Massachusetts
| $29K | -$17.2K | -549 | -41% |
|
32
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $29K | +$24.7K | +787 | New |
|
33
Corient Private Wealth
Miami,
Florida
| $28.5K | – | – | – |
|
34
CIBC Private Wealth Group
Atlanta,
Georgia
| $24.1K | – | – | – |
|
35
Bank of America
Charlotte,
North Carolina
| $19.7K | +$14.5K | +461 | +615% |
|
36
Barclays
London,
United Kingdom
| $17.1K | +$14.6K | +465 | New |
|
|
TRCT
37
Tower Research Capital (TRC)
New York
| $16.3K | -$35.7K | -1,138 | -72% |
|
38
JP Morgan Chase
New York
| $822 | +$659 | +21 | +2,100% |
|
39
Prudential Financial
Newark,
New Jersey
| – | -$40.9K | -1,240 | Closed |
|
40
UBS Group
Zurich,
Switzerland
| – | -$4.44K | -135 | Closed |
|
BDSX Hedge Fund Activity: Q4 2023 in Review
38 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q4 2023, worth a combined $34.1M — up 11% from $30.7M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BDSX positions and 3 closed out — a net gain of 2 holders — while 14 added to existing stakes and 10 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $124K. The largest seller was AIGH Capital Management, cutting an estimated $389K.
- 38 institutional investors held Biodesix (BDSX) as of Q4 2023, up from 37 in Q3 2023.
- Funds reported $34.1M of Biodesix stock for Q4 2023, up 11% quarter-over-quarter.
- 5 funds opened new Biodesix positions in Q4 2023 and 3 closed out, a net change of +2 holders.
- The largest Biodesix buyer in Q4 2023 was Geode Capital Management, an estimated $124K added.
- The largest Biodesix seller in Q4 2023 was AIGH Capital Management, an estimated $389K sold.
Based on aggregated 13F filings for Q4 2023.